Our division focuses on increasing the knowledge base for the design and evaluation of the most effective cervical cancer elimination strategies possible.
We conduct both basic and translational studies of the tumor virus Human Papillomavirus (HPV) and HPV-based prevention (screening and vaccination), including an international reference laboratory function where we sequence, document, and store all new Papillomaviruses as well as design and evaluate prevention in Sweden with a national quality register for cervical cancer prevention.
Larger EU projects at the division
- Examination of risk-stratified (personal) cancer screening (RISCC).
- HEAP (Human Exposome Assessment Platform) where we are developing an AI-driven data platform to evaluate the impact of the internal and external exposome on health.
During the Corona pandemic, we mapped the spread of SARS-CoV-2 among healthcare workers and how vaccination against the virus protects against infection and the spread of infection.
